ICON PLC (ICLR) vs Labcorp Holdings Inc. (LH)

ICON PLC and Labcorp Holdings Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $21.9B against $13.4B — 1.6× the size. Labcorp Holdings Inc. trades at the lower P/E: 25.4× against 257×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.41% against 3.26%. Labcorp Holdings Inc. has the higher net margin (6.99% vs 0.51%) and the higher return on invested capital (6.50% vs 1.57%). Across the 22 metrics below, Labcorp Holdings Inc. leads on 13 and ICON PLC on 9.

Valuation

Metric ICLR LH Diagnostics & Research median
P/E 257.44 25.44 33.95
P/S 1.60 1.76 4.87
P/B 1.41 2.94 3.12
Price to free cash flow 14.98 24.51 34.02
EV/EBITDA 23.55 14.70 25.20
EV/Sales 1.89 2.25 5.66
Earnings yield 0.39% 3.93% (1.75%)
Free cash flow yield 6.67% 4.08% (0.13%)

Profitability

Metric ICLR LH Diagnostics & Research median
Gross margin 23.91% 28.88% 50.89%
Operating margin 3.57% 10.43% (8.57%)
Net margin 0.51% 6.99% (6.37%)
Free cash flow margin 10.66% 8.16% 0.00%
Return on equity 0.45% 11.74% (2.92%)
Return on assets 0.26% 5.48% (6.71%)
Return on invested capital 1.57% 6.50% 0.00%

Growth

Metric ICLR LH Diagnostics & Research median
Revenue growth (TTM) 3.26% 6.41% 7.69%
EPS growth (last fiscal year) (69.57%) 18.33% —
Revenue growth, 5-year CAGR 24.15% (0.04%) 7.40%
Net income growth, 5-year CAGR (7.15%) (10.85%) 0.00%

Health

Metric ICLR LH Diagnostics & Research median
Debt to equity 0.36 0.69 0.11
Current ratio 0.95 1.80 2.02
Net debt to EBITDA 3.34 2.23 0.78

Dividend

Metric ICLR LH Diagnostics & Research median
Dividend yield — 0.98% 0.70%
Payout ratio 0.00 0.27 0.00

Size

Metric ICLR LH Diagnostics & Research median
Market cap 13.42b 21.86b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack